Last reviewed · How we verify
ISA specific
At a glance
| Generic name | ISA specific |
|---|---|
| Sponsor | James P. Rathmell, MD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- Rwanda Digital Dashboard Hybrid Type 3 Implementation Study (NA)
- Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial (NA)
- Engage Coaching (R33 Phase) (NA)
- Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance (NA)
- A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection (PHASE1, PHASE2)
- A Novel Multi-Modal Approach to Promote Functional Outcomes in Cognitively Frail Older Adults (NA)
- Diagnosis of Pheochromocytoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ISA specific CI brief — competitive landscape report
- ISA specific updates RSS · CI watch RSS
- James P. Rathmell, MD portfolio CI